influenza vaccine news

Novavax to Move Forward With Covid-19-Flu Vaccine

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its Covid-19 and influenza combination vaccine (CIC) and standalone influenza vaccines after a month-long clinical hold.

MarketWatch · 1d

Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, Sanofi will have the sole right to use Novavax's existing Covid-19 vaccine in combination with its own flu vaccine.

emjreviews.com · 14h

FDA Lifts Hold on COVID-Flu Combo Vaccine Trial

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the vaccine and a reported adverse neurological event. This decision enables Novavax to resume late-stage testing.

Armed robbery in Revesby6h

Needle-free Influenza Vaccine On Horizon

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

Becker's Hospital Review14h

FDA lifts clinical hold on combined COVID-19-influenza vaccine trials

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC ... confirming that the event was not related to the investigational ...

ThePrint on MSN19h

Govt panel suggests influenza vaccination in TN in July, up north in October & rest of India in May

This is the first time that a proposal for different timings for flu shots has been introduced in India. It hinges on the ...

Business Insider21h

Novavax Resumes Phase 3 Vaccine Trials After FDA Hold

The latest update is out from Novavax ( (NVAX)). Novavax, a leader in vaccine development, announced the FDA’s removal of a clinical hold on their COVID-19-Influenza combination and influenza ...

Business Wire1d

Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza ...